FDA Probing Abbott Device's Higher Rate Of Cardiac Events
By Emily Field · March 20, 2017, 5:44 PM EDT
The U.S. Food and Drug Administration recently told health care providers that there's an increased rate of major cardiac events seen in patients treated with an Abbott Inc. medical device implanted...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login